Results 131 to 140 of about 805 (150)

From adhalinopathies to alpha-sarcoglycanopathies: An overview

Neuromuscular Disorders, 1996
M, Jeanpierre, A, Carrié, F, Piccolo, F, Leturcq, K, Azibi, C, De Toma, C, Beldjord, L, Merlini, T, Voit, N, Romero, Y, Sunada, F M, Tomé, M, Fardeau, K P, Campbell, J C, Kaplan   +14 more
openaire   +2 more sources

Sarcoglycanopathies: Clinical, Molecular and Genetic Characteristics, Epidemiology, Diagnostics and Treatment Options

Russian Journal of Genetics, 2018
O P Ryzhkova
exaly  

G.P.8.13 Cardiomyopathy in sarcoglycanopathies

Neuromuscular Disorders, 2007
S. Schade van Westrum, W. de Voogt, L. Dekker, I. Ginjaar, M. de Visser, A. van der Kooi   +5 more
openaire   +1 more source

LGMD2E is the most common type of sarcoglycanopathies in the Iranian population

Journal of Neurogenetics, 2017
Mahmoud Reza Ashrafi, Hossein Najmabadi, Kimia Kahrizi   +2 more
exaly  

Hip Abduction Sign: A New Clinical Sign in Sarcoglycanopathies

Journal of Clinical Neuromuscular Disease, 2001
Rajendra Kumar Singh
exaly  

A regional panorama of sarcoglycanopathies

2014
Diniz, G., Hazan, F., Yildirim, H. T., Unalp, A., Polat, M., Serdaroglu, G., Ture, S., Akhan, G., Tukun, A.   +8 more
openaire   +1 more source

Regeneration in sarcoglycanopathies: expression studies of sarcoglycans and other muscle proteins

Journal of the Neurological Sciences, 1999
Corrado Angelini, Marina Fanin
exaly  

Combination treatment of sarcoglycanopathies

2019
RICHARD ISABELLE, SANDONÀ DORIANNA
openaire   +2 more sources

Sarcoglycanopathies: Their pathogenesis and clinical features

Electroencephalography and Clinical Neurophysiology, 1997
openaire   +1 more source

IMMUNOLOCALIZATION OF DGC IN THE SARCOGLYCANOPATHY

2000
ANASTASI, Giuseppe Pio, CINELLI M. P., CUTRONEO, Giuseppina, MAGAUDDA, Ludovico, MESSINA L., RIZZO G., VOLPI N.   +6 more
openaire   +1 more source